Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Male~2. Ages 18-55 (inclusive)~3. Cannabis Dependence~Exclusion Criteria:~1. Allergies or intolerance to FAAH-Inhibitors~2. Current significant medical or other comorbidities

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- PF-04457845 (Type: ACTIVE_COMPARATOR): 2/3 of subjects will be randomized to fatty acid amide hydrolase (FAAH) inhibitor 4mg
- Placebo (sugar pill) (Type: PLACEBO_COMPARATOR): 1/3 of subjects will be randomized to placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).